Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial
Titel:
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial
Auteur:
Wainberg, Zev A. Kang, Yoon-Koo Lee, Keun-Wook Qin, Shukui Yamaguchi, Kensei Kim, In-Ho Saeed, Anwaar Oh, Sang Cheul Li, Jin Turk, Haci Mehmet Teixeira, Alexandra Hitre, Erika Udrea, Adrian A. Cardellino, Giovanni Gerardo Sanchez, Raquel Guardeño Zahlten-Kümeli, Anita Taylor, Kate Enzinger, Peter C.